Recruiting studies: Del 5Q

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UK SMA Patient Registry
Phase N/A · 1 location(s) · Newcastle University · NCT04292574 Biocollection in MyeloDysplastic Syndrome (P-MDS)
NA · 1 location(s) · University Hospital, Brest · NCT04869683 Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06303193 Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant t
Phase 2 · 23 location(s) · Associazione Qol-one · NCT05924100

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.